Related Experiment Video

Updated: Jan 7, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

620

Centering Community Engagement in a Hypertension Clinical Trial: Strategies to Engage Rural Black Patients in the

Stephanie Hart1, Doyle M Cummings2,3, Monika M Safford4

  • 1Nursing Fellow, National Clinician Scholars Program (NCSP), Duke Clinical and Translational Science Institute, Duke University School of Nursing, Durham, NC, USA.

Journal of Racial and Ethnic Health Disparities
|December 20, 2025
PubMed

Insights

This study details strategies for recruiting and retaining rural Black Americans with uncontrolled hypertension in clinical trials. Lessons learned aim to improve engagement with under-represented communities in health research.

Area of Science:

  • Clinical Trials
  • Health Disparities
  • Community-Engaged Research

Background:

  • Rural Black Americans face high hypertension prevalence and complications.
  • These populations are often excluded from clinical trials.
  • Effective recruitment and retention strategies are crucial.

Purpose of the Study:

  • To describe experiences supporting recruitment and retention of rural Black patients with uncontrolled hypertension.
  • To share challenges and lessons learned from a cluster-randomized clinical trial.
  • To inform future research engagement with historically excluded communities.

Main Methods:

  • Community-engaged research principles were foundational.
  • Strategies focused on trust-building, transparency, and shared leadership.
  • A cluster-randomized clinical trial design was employed.

Main Results:

  • The report focuses on enrollment and engagement experiences.
  • Specific challenges encountered during recruitment and retention are discussed.
  • Lessons learned provide insights for future community engagement.

Conclusions:

  • Authentic engagement requires long-standing community partnerships.
  • Trust, transparency, and shared leadership are key to success.
  • Future research must actively involve under-represented communities as partners.

Keywords:
Clinical trialsCommunity engagementHypertensionRecruitment

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.7K

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
328
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
556
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.3K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290